onchillespharma.com valuation and analysis

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
# START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://onchillespharma.com/sitemap_index.xml # --------------------------- # END YOAST
Meta Tags
Title Onchilles Pharma | Neutrophils and
Description ABOUT ONCHILLES Developing first-in-class cancer therapeutics with a pathway activated by neutrophils to induce apoptosis in cancer
Keywords N/A
Server Information
WebSite onchillespharma favicononchillespharma.com
Host IP 107.180.26.63
Location United States
Related Websites
Site Rank
More to Explore
onchillespharma.com Valuation
US$3,390,778
Last updated: 2023-05-10 17:02:15

onchillespharma.com has Semrush global rank of 3,121,497. onchillespharma.com has an estimated worth of US$ 3,390,778, based on its estimated Ads revenue. onchillespharma.com receives approximately 391,244 unique visitors each day. Its web server is located in United States, with IP address 107.180.26.63. According to SiteAdvisor, onchillespharma.com is safe to visit.

Traffic & Worth Estimates
Purchase/Sale Value US$3,390,778
Daily Ads Revenue US$3,130
Monthly Ads Revenue US$93,899
Yearly Ads Revenue US$1,126,782
Daily Unique Visitors 26,083
Note: All traffic and earnings values are estimates.
DNS Records
Host Type TTL Data
onchillespharma.com. A 7199 IP: 107.180.26.63
onchillespharma.com. NS 3600 NS Record: ns42.domaincontrol.com.
onchillespharma.com. NS 3600 NS Record: ns41.domaincontrol.com.
onchillespharma.com. MX 600 MX Record: 0 onchillespharma-com.mail.protection.outlook.com.
onchillespharma.com. TXT 600 TXT Record: google-site-verification=lajXcG1iHMOO-r-v3Fv0LBDwEH-3YHdqRmY19Gmo06s
onchillespharma.com. TXT 600 TXT Record: v=verifydomain MS=4657611
onchillespharma.com. TXT 600 TXT Record: v=spf1 include:spf.protection.outlook.com -all
onchillespharma.com. TXT 600 TXT Record: 60EFF69CE8
HtmlToTextCheckTime:2023-05-10 17:02:15
Home Science Therapeutics Team Careers NewsRoom Contact ONCHILLES PHARMA Toggle Menu Revealing Innate Immune Pathways to Build FIRST-IN-CLASS MYELOID-FOCUSED CANCER THERAPEUTICS ABOUT ONCHILLES PHARMA Onchilles Pharma is a global drug discovery and development company that leverages novel neutrophil and macrophage biology to develop the next generation of immunotherapies to treat cancer. These myeloid-focused therapeutics exploit new fundamental pathways of the innate immune system and have the potential for universal anti-cancer activity, independent of genetic mutation. Based on this novel myeloid biology, Onchilles is developing a pipeline of first-in-class biologic drug candidates with the potential to be broadly effective against a wide range of cancers. NOVEL NEUTROPHIL AND MACROPHAGE BIOLOGY EMPOWERS ANTI-TUMOR IMMUNITY Neutrophils and macrophages are among the most abundant white blood cells in the immune system, serving as the first line of defense against infections,
HTTP Headers
HTTP/1.1 200 OK
Date: Wed, 03 Nov 2021 03:27:32 GMT
Server: Apache
Vary: User-Agent,Accept-Encoding
Upgrade: h2,h2c
Connection: Upgrade
Last-Modified: Mon, 01 Nov 2021 17:00:36 GMT
Accept-Ranges: bytes
Content-Length: 64585
Cache-Control: max-age=0, no-cache, no-store, must-revalidate
Pragma: no-cache
Expires: Mon, 29 Oct 1923 20:30:00 GMT
Content-Type: text/html; charset=UTF-8
onchillespharma.com Whois Information
Domain Name: ONCHILLESPHARMA.COM
Registry Domain ID: 2175032381_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.godaddy.com
Updated Date: 2020-10-09T12:44:27Z
Creation Date: 2017-10-16T17:39:39Z
Registry Expiry Date: 2021-10-16T17:39:39Z
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: 480-624-2505
Domain Status: ok https://icann.org/epp#ok
Name Server: NS41.DOMAINCONTROL.COM
Name Server: NS42.DOMAINCONTROL.COM
DNSSEC: unsigned
>>> Last update of whois database: 2021-09-28T08:17:43Z <<<